| MeSH term | MeSH ID | Detail |
|---|---|---|
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
816-94-4
816-94-4 is a lipid of Glycerophospholipids (GP) class. 816-94-4 is associated with abnormalities such as Gigantism, Pulmonary Hypertension, Neutropenia, Serum Sickness and Urticaria. The involved functions are known as pulmonary effects, Hemodynamics, Stereochemistry, Host defense and Blood Circulation. 816-94-4 often locates in vesicle, Blood, biological membrane, soluble and Cardiopulmonary. The associated genes with 816-94-4 are pentaglobulin, EMILIN1 gene and FASTK Gene. The related lipids are Liposomes, dimyristoylphosphatidylglycerol, Lipopolysaccharides, Unilamellar Liposomes and Unilamellar Vesicles.
Cross Reference
Introduction
To understand associated biological information of 816-94-4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 816-94-4?
816-94-4 is suspected in Pulmonary Hypertension, Cholera, Gigantism, Neutropenia, Serum Sickness, Urticaria and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 816-94-4
PubChem Associated disorders and diseases
What pathways are associated with 816-94-4
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 816-94-4?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 816-94-4?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 816-94-4?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 816-94-4?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 816-94-4?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 816-94-4
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Suzuki R et al. | A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. | 2009 | J Control Release | pmid:19000727 |
| Paasonen L et al. | Gold nanoparticles enable selective light-induced contents release from liposomes. | 2007 | J Control Release | pmid:17628159 |
| Unezaki S et al. | Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes. | 1993 | J Drug Target | pmid:8069570 |
| Ouadahi S et al. | Liposomal formulations for oral immunotherapy: in-vitro stability in synthetic intestinal media and in-vivo efficacy in the mouse. | 1998 | J Drug Target | pmid:9771618 |
| Kallinteri P et al. | Characterization, stability and in-vivo distribution of asialofetuin glycopeptide incorporating DSPC/CHOL liposomes prepared by mild cholate incubation. | 2001 | J Drug Target | pmid:11697109 |
| Iga K et al. | Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake. | 1994 | J Drug Target | pmid:7812694 |
| Ward RJ et al. | Method for forming two-dimensional paracrystals of biological filaments on lipid monolayers. | 1990 | J Electron Microsc Tech | pmid:2332809 |
| Ghanbari Safari M and Hosseinkhani S | Lipid composition of cationic nanoliposomes implicate on transfection efficiency. | 2013 | J Liposome Res | pmid:23594237 |
| Sade A et al. | Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles. | 2010 | J Liposome Res | pmid:19848445 |
| Johnston MJ et al. | Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. | 2008 | J Liposome Res | pmid:18569449 |
| Kirby CJ and Gregoriadis G | Preparation of liposomes containing factor VIII for oral treatment of haemophilia. | 1984 Jan-Mar | J Microencapsul | pmid:6443849 |
| Moraes AM et al. | Preparation and characterization of liposomal systems entrapping the boronated compound o-carboranylpropylamine. | 1999 Sep-Oct | J Microencapsul | pmid:10499844 |
| Montero MT et al. | Encapsulation of a quinolone in liposomes. Location and effect on lipid bilayers. | 1994 Jul-Aug | J Microencapsul | pmid:7931941 |
| Oguchi T et al. | DSPC/DLPC mixed films supported on silica: a QCM-D and friction force study. | 2011 | J Oleo Sci | pmid:21427514 |
| Kafle A et al. | Effects of β-Sitosteryl Sulfate on the Phase Behavior and Hydration Properties of Distearoylphosphatidylcholine: a Comparison with Dipalmitoylphosphatidylcholine. | 2018 | J Oleo Sci | pmid:29526873 |
| Embree L et al. | Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection. | 1997 | J Pharm Biomed Anal | pmid:9502163 |
| Franzen U et al. | Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage. | 2011 | J Pharm Biomed Anal | pmid:21282028 |
| Burke TG and Gao X | Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine. | 1994 | J Pharm Sci | pmid:7965676 |
| ErdoÄŸ A et al. | In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines. | 2013 | J Pharm Sci | pmid:23897281 |
| McNeil SE et al. | Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system. | 2011 | J Pharm Sci | pmid:21374619 |